| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 400,05 | 401,35 | 11:44 | |
| 400,05 | 401,35 | 11:41 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 403,40 | 1 | |||
| 402,85 | 24 | |||
| 402,35 | 40 | |||
| 401,85 | 21 | |||
| 401,75 | 21 | |||
| 401,65 | 21 | |||
| 401,55 | 21 | |||
| 401,45 | 21 | |||
| 401,40 | 62 | |||
| 400,65 | 46 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/iui1.htm [/URL] | ||||
| 21 | 397,80 | |||
| 15 | 397,75 | |||
| 3 | 396,20 | |||
| 24 | 396,15 | |||
| 1 | 395,55 | |||
| 24 | 395,40 | |||
| 24 | 394,60 | |||
| 24 | 393,40 | |||
| 24 | 392,20 | |||
| 24 | 390,65 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 184 | 1,511 | 278 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 11:06:34 | 402,20 | 5 |
| 11:01:16 | 399,80 | 15 |
| Tagesumsatz Xetra | +2,95 +0,74 % | 58 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | 10 | Zacks | ||
| Mo | Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year? | 6 | The Motley Fool | ||
| INTUITIVE SURGICAL Aktie jetzt für 0€ handeln | |||||
| Mo | Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street's Sell-Off Misses the Point. | 6 | The Motley Fool | ||
| So | Why Intuitive Surgical (ISRG) Just Cracked the Top 10 Best Healthcare Stocks List | 3 | Insider Monkey | ||
| Do | ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising? | 7 | Zacks |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Di | Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth | Business Wire | Third-quarter 2026 sales of $2.7 billion, +5%, +5% constant currency1 (cc), vs. third-quarter 2025 Year-to-date 2026 sales of $8.2 billion, +7%, +6% cc, vs. the same period last year ... ► Artikel lesen | |
| 07:39 | Alcon spürt Konkurrenzdruck bei künstlichen Augenlinsen | Moneycab | Genf / Fort Worth - Der Augenheilmittel-Konzern Alcon ist im dritten Quartal 2026 weiter gewachsen - trotz anhaltenden Konkurrenzdrucks in einigen Bereichen. Die im Sommer gerade erst angehobenen Jahresziele... ► Artikel lesen | |
| Di | Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth | Business Wire | Third-quarter 2026 sales of $2.7 billion, +5%, +5% constant currency1 (cc), vs. third-quarter 2025 Year-to-date 2026 sales of $8.2 billion, +7%, +6% cc, vs. the same period last year ... ► Artikel lesen | |
| Di | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | ACCESS Newswire | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| Di | Alcon Q3 Profit Rises 10%; Tightens FY26 Outlook | AFX News | WASHINGTON (dpa-AFX) - Alcon Inc. (ALC), an eye care company offering surgical and vision care products, on Tuesday reported an increase in profit and revenues for the third quarter, driven... ► Artikel lesen |